Ilumya 100 mg/mL single-dose prefilled syringe Images
Generic Name: tildrakizumab
This medication has been identified as Ilumya 100 mg/mL single-dose prefilled syringe. It is supplied by Sun Pharmaceutical Industries Inc.
Ilumya is used in the treatment of Plaque Psoriasis; Psoriasis and belongs to the drug class interleukin inhibitors. Ilumya 100 mg/mL single-dose prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Ilumya
- Generic Name
- tildrakizumab
- Strength
- 100 mg/mL single-dose prefilled syringe
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceutical Industries Inc.
- National Drug Code (NDC)
- 47335-0177
More about Ilumya (tildrakizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.